All lobbying filings

UPSTREAM CONSULTING

Lobbying for PRIMUS PHARMACEUTICAL · Pharmaceutical drug manufacturing

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 30, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Virginia

Official filing document

Conviction disclosures 1

A registrant must disclose criminal convictions of the lobbyists it lists, under the Honest Leadership and Open Government Act. This is the filer's own wording.

MCCLAIN C HADDOW 1987

9/15/1987, U.S. District Court, 18 U.S.C. Section 208(a), conflict of interest (2 counts)

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Protect access of medical foods.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.